Abstract
Nonfluent aphasia is a language disorder characterized by simplified sentence structures as well as word-level abnormalities such as a reduced use of verbs and function words. According to the predominant account of the disorder, both structural and word-level features are caused by a core deficit in the processing of syntax. Under this account, however, it remains unclear why nonfluent patients choose semantically richer verbs and may have an intact comprehension of verbs and function words.
Here, we propose and test the hypothesis that the word-level features of nonfluency reflect a process that selects lexically richer words to increase the information content of sentences.
We use a computational linguistic method to measure the information content of sentences in the language of patients with nonfluent primary progressive aphasia (nfvPPA) (n = 36) and healthy controls (n = 133). We measure sentence information using surprisal, a metric calculated by the average probability of occurrence of words in a sentence given their preceding context.
We found that by packaging their structurally simple sentences with lower frequency words, nfvPPA patients produce sentences with similar surprisal as that of healthy speakers. Furthermore, we found that higher sentence surprisal in nfvPPA correlates with a lower function-to-all-word ratio, a lower verb-to-noun ratio, and a higher heavy-to-all-verb ratio.
Surprisal is an effective quantitative index of sentence information. Using surprisal allows for testing an account of nonfluent aphasia that regards word-level features of nonfluency as adaptive rather than defective symptoms, a finding that may entail revisions in therapeutic approaches to nonfluent speech.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by NIH grants R01 DC014296, R21 DC019567, R21 AG073744, and by the Tommy Rickles Chair in Primary Progressive Aphasia Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The recruitment of healthy controls was approved by the Brain Resilience in Aging: Integrated Neuroscience Studies (BRAINS) program at MGH. Obtaining informed consent from all patients as well as the recruitment of all healthy controls were performed in accordance with guidelines established by the Mass General Brigham Healthcare System Institutional Review Boards which govern human subjects research at MGH and specifically approved this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All codes are available at https://github.com/jmichaelov/PsychFormers. Access to patients data will be granted through a request to Dr. Bradford Dickerson, brad.dickerson{at}mgh.harvard.edu
